Valeant Pharma (VRX), Retrophin (RTRX) Continue Slump Amid Senate Committee Price Hike Investigation
Go back to Valeant Pharma (VRX), Retrophin (RTRX) Continue Slump Amid Senate Committee Price Hike Investigation| RETROPHIN (NASDAQ: RTRX) | Delayed: 24.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.25 | 52 Week High | $24.57 | |||
| Open | $4.35 | 52 Week Low | $11.60 | |||
| Day High | $24.25 | P/E | N/A | |||
| Day Low | $24.25 | EPS | $-4.30 | |||
| Volume | 217,426 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||

